Author

E. Ke

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. A. Yela· 1 shared A. Babnis· 1 shared A. R. Cliffe· 1 shared B. E. Kelly· 1 shared C. Boutell· 1 shared E. Casarez· 1 shared H. Baidas· 1 shared H. Zong· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. Yela

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Quantitative clonal analysis reveals vast heterogeneity among fallopian tube cells for ovarian cancer-initiation and progression

J. Zeng, A. A. Yela, E. Casarez, Y. Jiang, L. Wang, B. E. Kelly, E. Ke, T. M. Jenkins, K. A. Atkins, K. A. Janes, J. K. Slack-Davis, H. Zong

This study uses quantitative clonal tracing in mice to show that only a rare subset of distal fallopian tube cells can initiate and progress serous ovarian cancer.

bioRxiv · Jan 23, 2022 · PreprintCancer Biology

PML-Dependent Memory of Type I Interferon Treatment Results in a Restricted Form of HSV Latency

J. B. Suzich, S. R. Cuddy, H. Baidas, S. Dochnal, E. Ke, A. Babnis, C. Boutell, A. R. Cliffe

This study shows that type I interferon treatment during HSV-1 infection leads to restricted latency by altering viral genome positioning through PML-NBs.

bioRxiv · Feb 3, 2021Immunology